Accelerated and blastic phase of chronic myeloid leukemia-Reference-Cited by-同舟云学术

Accelerated and blastic phase of chronic myeloid leukemia

Published:2000-02 Issue:1 Volume:1 Page:51-62
ISSN:1527-2729
Container-title:Current Treatment Options in Oncology
language:en
Short-container-title:Curr. Treat. Options in Oncol.

Author:

Dutcher Janice P.,Wiernik Peter H.

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Oncology

Link

http://link.springer.com/content/pdf/10.1007/s11864-000-0015-z.pdf

Reference33 articles.

1. Faderl S, Talpaz M, Estrov Z, Kantarjian HM: Chronic myelogenous leukemia: Biology and therapy. Ann Intern Med 1999, 131:207–219. This article provides a comprehensive review of the biology of CML and the management of the chronic phase of the disease. It also introduces new approaches and potential new agents for preventing or delaying progression.

2. Italian Cooperative Study Group on Chronic Myeloid Leukemia and Italian Group for Bone Marrow Transplantation: Monitoring treatment and survival in chronic myeloid leukemia. J Clin Oncol 1999, 17:1858–1868. This article provides a longitudinal follow-up of a database of 840 CML patients treated with chemotherapy, interferon, or allogeneic bone marrow transplantation. It provides an analysis of factors that affect outcome and that delineate risk groups to help make treatment decisions.

3. Arlin ZA, Silver RT, Bennett JM: Blastic phase of chronic myeloid leukemia: a proposal for standardization of diagnostic and response criteria. Leukemia 1990, 4:755–757.

4. Anger B, Carbonell F, Braunger I, et al.: Blast crisis of Philadelphia chromosome-positive chronic myeloid leukemia. Blut 1988, 57:131–137.

5. Dutcher JP, Lee S, Paietta E, et al.: Phase II study of carboplatin in blast crisis of chronic myeloid leukemia: Eastern Cooperative Oncology Group Study E1992. Leukemia 1998, 12:1037–1040.

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. In Silico Molecular Modeling of Four New Afatinib Derived Molecules Targeting the Inhibition of the Mutated Form of BCR-ABL T315I;Molecules;2024-09-08

2. Evaluation of anti-tumor effect of the exopolysaccharide from new cold-adapted yeast, Rhodotorula mucilaginosa sp. GUMS16 on chronic myeloid leukemia K562 cell line;International Journal of Biological Macromolecules;2022-05

3. Blast crisis of chronic myeloid leukemia initially presenting as severe acute intracerebral hemorrhage;Journal of Family Medicine and Primary Care;2020

4. Clonal Hematopoiesis with Oncogenic Potential (CHOP): Separation from CHIP and Roads to AML;International Journal of Molecular Sciences;2019-02-12

5. Differential clinical and prognostic impact of myeloid sarcoma vs medullary myeloid blast phase of chronic myelogenous leukemia in the era of tyrosine kinase inhibitor therapy;Blood Cancer Journal;2016-05